Medicare Enrolled

Dr. Hugo Lara-Martinez, MD

Hematology & Oncology · Houston, TX
1515 HOLCOMBE BLVD, Houston, TX 77030
7137926161
Registered in NPPES since 2018
NPI: 1295228963 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lara-Martinez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lara-Martinez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lara-Martinez

Dr. Hugo Lara-Martinez is a hematology & oncology specialist in Houston, TX, with 8 years of NPI registration.

Between the years covered by Open Payments, Dr. Lara-Martinez received a total of $61,753 from 46 pharmaceutical and/or device companies across 253 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lara-Martinez is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 8 years of NPI registration $61,753 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$61,753
Total received (2021-2024)
Avg $15,438/year across 4 years
Top 10% in TX for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
253
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$51,475
2023
$5,376
2022
$3,539
2021
$1,363

Payments by company (2024)

Genentech, Inc.
$50,000
GENZYME CORPORATION
$286
Alexion Pharmaceuticals, Inc.
$201
EMD Serono, Inc.
$176
Janssen Biotech, Inc.
$165
ABBVIE INC.
$152
E.R. Squibb & Sons, L.L.C.
$134
Merck Sharp & Dohme LLC
$59
Incyte Corporation
$56
BeiGene USA, Inc.
$43
Celgene Corporation
$30
PFIZER INC.
$30
Novartis Pharmaceuticals Corporation
$29
Blueprint Medicines Corporation
$28
SERVIER PHARMACEUTICALS LLC
$24
Eisai Inc.
$24
Daiichi Sankyo Inc.
$20
BTG International, Inc.
$18
Top 3 companies account for 98.1% of 2024 payments
All-time payments by company (2021-2024) ›
Genentech, Inc.
$50,000
GENZYME CORPORATION
$3,459
Alexion Pharmaceuticals, Inc.
$1,096
ABBVIE INC.
$743
Incyte Corporation
$614
Celgene Corporation
$517
Janssen Biotech, Inc.
$515
JAZZ PHARMACEUTICALS INC.
$489
SECURA BIO, INC.
$469
AstraZeneca Pharmaceuticals LP
$371
Amgen Inc.
$364
Seagen Inc.
$267
Merck Sharp & Dohme LLC
$244
E.R. Squibb & Sons, L.L.C.
$233
Exelixis Inc.
$225
EMD Serono, Inc.
$190
Lilly USA, LLC
$145
SERVIER PHARMACEUTICALS LLC
$135
Aadi Bioscience, Inc.
$134
Apellis Pharmaceuticals, Inc.
$130
Pharmacyclics LLC, an AbbVie Company
$125
ImmunoGen, Inc.
$117
Novartis Pharmaceuticals Corporation
$109
Ipsen Biopharmaceuticals, Inc
$97
Eisai Inc.
$69
AbbVie Inc.
$69
Daiichi Sankyo Inc.
$67
Bayer Healthcare Pharmaceuticals Inc.
$62
BeiGene USA, Inc.
$60
Alnylam Pharmaceuticals Inc.
$59
Deciphera Pharmaceuticals Inc.
$58
Blueprint Medicines Corporation
$56
PFIZER INC.
$56
Takeda Pharmaceuticals U.S.A., Inc.
$54
Bayer HealthCare Pharmaceuticals Inc.
$50
AVEO Pharmaceuticals, Inc.
$49
Genentech USA, Inc.
$43
Regeneron Healthcare Solutions, Inc.
$32
Puma Biotechnology, Inc.
$28
Kite Pharma, Inc.
$28
ADC Therapeutics America, Inc.
$27
Gilead Sciences, Inc.
$24
Agios Pharmaceuticals, Inc.
$23
Emmaus Medical, Inc.
$19
BTG International, Inc.
$18
Servier Pharmaceuticals LLC
$17
Top 3 companies account for 88.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · Asparlas · BAVENCIO · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · COPIKTRA · Cabometyx · DARZALEX · ELAHERE · ELITEK · ENHERTU · ENJAYMO · Elahere · Endari · Enhertu · FOTIVDA · FYARRO · GIVLAARI · IBRANCE · ICLUSIG · IMBRUVICA · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LIVTENCITY · LYNPARZA · Lenvima · MONJUVI · Nplate · Nubeqa · ONUREG · OXBRYTA · PEMAZYRE · PROMACTA · PYRUKYND · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RYLAZE · Revlimid · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · Somatuline Depot · Stivarga · TAGRISSO · TECVAYLI · TIBSOVO · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VYXEOS · Voraxaze · ZEPZELCA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Houston?
Compare hematology & oncology specialists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
202
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lara-Martinez is a hematology & oncology specialist.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Lara-Martinez receive payments from pharmaceutical companies?
Yes. Dr. Lara-Martinez received a total of $61,753 from 46 companies across 253 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Lara-Martinez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Hematology & Oncology Specialists in Houston
Browse hematology & oncology specialists in Houston ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Genentech, Inc. Payments to Doctors
See all physicians who received payments from Genentech, Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →